• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase

tetano

Editor, Senior Moderator
Bioorg Med Chem Lett. 2014 Jul 18. pii: S0960-894X(14)00734-3. doi: 10.1016/j.bmcl.2014.07.010. [Epub ahead of print]
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
Rakers C1, Schwerdtfeger SM2, Mortier J1, Duwe S2, Wolff T2, Wolber G3, Melzig MF4.
Author information
Abstract

The constant risk of emerging new influenza virus strains that are resistant to established inhibitors like oseltamivir leaves influenza neuraminidase (NA) a prominent target for drug design. The inhibitory activity of several flavonoid derivatives was experimentally tested in comparison to oseltamivir for the NA expressed by the seasonal influenza virus strains A/California/7/09 (A(H1N1)pdm09), A/Perth/16/09 (A(H3N2)), and B/Brisbane/60/08. IC50 values of polyphenols confirmed moderate inhibition in the μM range. Structurally, the amount and site of glycosylation of tested flavonoids have no significant influence on their inhibitory potency. In a pharmacophore-based docking approach the structure-activity relationship was evaluated. Molecular dynamics simulations revealed highly flexible parts of the enzyme and the contribution of salt bridges to the structural stability of NA. The findings of this study elucidate the impact of flavonoids on viral neuraminidase activity and the analysis of their modes of action provide valuable information about the mechanism of NA inhibition.

Copyright ? 2014 Elsevier Ltd. All rights reserved.
KEYWORDS:

Docking; Flavonoids; Influenza; Molecular dynamics; Neuraminidase

PMID:
25096296
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25096296
 
Back
Top Bottom